Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Cancer Therapy Global Market Report 2025
Download Free Sample Buy Now
Global Cancer Therapy Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Cancer Therapy Global Market Report 2025

By Therapy Type (Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types), By Cancer Type (Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types), By End User (Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Cancer Therapy Market?

Cancer therapy refers to the treatment used to eliminate or control cancer cells in the body. It includes various approaches such as surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The choice of treatment depends on the type, stage, and location of the cancer, as well as the patient's overall health.

The main types of cancer therapy include chemotherapy, targeted therapy, immunotherapy, radiotherapy, and others. Chemotherapy is a type of cancer treatment that uses powerful drugs to kill or stop the growth of rapidly dividing cancer cells in the body. It is used for various cancer types such as blood cancer, breast cancer, prostate cancer, gastrointestinal cancer, gynecologic cancer, respiratory or lung cancer, and other cancer types and is used by several end users such as hospitals, specialty clinics, and cancer and radiation therapy centers.

Cancer Therapy Market Size and growth rate 2025 to 2029: Graph

What Is The Cancer Therapy Market Size 2025 And Growth Rate?

The cancer therapy market size has grown rapidly in recent years. It will grow from $190.44 billion in 2024 to $210.44 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to the increasing prevalence of cancer worldwide, the rising adoption of chemotherapy treatments, growing awareness about early cancer diagnosis, the rising availability of oncology specialists, and growing access to hospital-based treatment services.

What Is The Cancer Therapy Market Growth Forecast?

The cancer therapy market size is expected to see rapid growth in the next few years. It will grow to $310.85 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growing demand for personalized cancer therapies, increasing focus on outpatient cancer care, rising adoption of immunotherapy, expanding access to healthcare in emerging economies, and growing incidence of lifestyle-related cancers. Major trends in the forecast period include technological advancements in cancer diagnostics, innovations in targeted drug delivery, investment in research and development of biologics, development of AI-based treatment planning, and innovation in minimally invasive cancer surgeries.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

How Is The Cancer Therapy Market Segmented?

The cancer therapy market covered in this report is segmented –

1) By Therapy Type: Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types

2) By Cancer Type: Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types

3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers

Subsegment:

1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, corticosteroids, Other Chemotherapy Drugs

2) By Targeted Therapy: Monoclonal Antibodies, Tyrosine Kinase Inhibitors (TKIs), mTOR Inhibitors, Proteasome Inhibitors, PARP Inhibitors, Other Targeted Agents

3) By Immunotherapy: Immune Checkpoint Inhibitors, CAR T-cell Therapy, Cancer Vaccines, Cytokines, Oncolytic Virus Therapy, Other Immunotherapies

4) By Radiotherapy: External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (Brachytherapy), Systemic Radiation Therapy, Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT)

5) By Other Therapy Types: Hormone Therapy, Stem Cell Transplant, Photodynamic Therapy, Cryoablation, Hyperthermia Therapy

What Is Driving The Cancer Therapy Market? Rising Cancer Prevalence Driving Growth Of The Market Due To Aging Population And Growing Treatment Needs

The increasing prevalence of cancer is expected to propel the growth of the cancer therapy market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. Cancer is rising primarily due to increasing exposure to environmental carcinogens such as pollution and tobacco smoke. Cancer therapy plays a crucial role in managing the rising prevalence of cancer by treating existing cases, improving survival rates, and reducing disease progression. For instance, in February 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, global cancer incidence is expected to reach over 35 million new cases by 2050, representing a 77% increase from the estimated 20 million cases recorded in 2022. Therefore, the increasing prevalence of cancer is driving the cancer therapy market.

Who Are The Major Players In The Global Cancer Therapy Market?

Major companies operating in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., Aptadel Therapeutics S.L.

What Are The Key Trends Of The Global Cancer Therapy Market? Dr. Reddy’s Launches India’s First Immuno-Oncology Drug For Nasopharyngeal Cancer

Major companies operating in the cancer therapy market are focusing on developing innovative therapies, such as immuno-oncology drugs, to enhance treatment effectiveness by harnessing the body's immune system to target and destroy cancer cells. Immuno-oncology drugs are a class of cancer treatments that stimulate or enhance the body’s own immune system to recognize and attack cancer cells more effectively. For instance, in December 2024, Dr. Reddy’s Laboratories Ltd., an India-based pharmaceutical company, introduced Toripalimab, the first and only immuno-oncology medication authorized for the treatment of nasopharyngeal cancer, in India. This launch brings a new, targeted treatment option for patients suffering from this rare and aggressive cancer, potentially improving outcomes through advanced immune system engagement. The availability of toripalimab in India underscores Dr. Reddy’s commitment to expanding access to cutting-edge cancer therapies in underserved areas.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Cancer Therapy Market? Pfizer's Acquisition Of Seagen To Strengthen Oncology Portfolio

In December 2023, Pfizer Inc., a US-based pharmaceutical company, acquired Seagen Inc. for $43 billion. With this acquisition, Pfizer aims to strengthen its oncology portfolio by integrating Seagen’s advanced ADC technology for more precise cancer treatments. Seagen Inc. is a US-based company focused on developing ADCs that precisely target cancer cells while minimizing harm to healthy tissue.

What Is The Regional Outlook For The Global Cancer Therapy Market?

North America was the largest region in the cancer therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cancer therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cancer Therapy Market?

The cancer therapy market includes revenues earned by entities by providing services such as hormone therapy, stem cell transplant, cryoablation, and photodynamic therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cancer Therapy Industry?

The cancer therapy market research report is one of a series of new reports from The Business Research Company that provides cancer therapy market statistics, including the cancer therapy industry global market size, regional shares, competitors with the cancer therapy market share, detailed cancer therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the cancer therapy industry. This cancer therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Cancer Therapy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $210.44 billion
Revenue Forecast In 2034 $310.85 billion
Growth Rate CAGR of 10.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The cancer therapy market covered in this report is segmented –
1) By Therapy Type: Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types
2) By Cancer Type: Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types
3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers Subsegment:
1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Other Chemotherapy Drugs
2) By Targeted Therapy: Monoclonal Antibodies, Tyrosine Kinase Inhibitors (TKIs), mTOR Inhibitors, Proteasome Inhibitors, PARP Inhibitors, Other Targeted Agents
3) By Immunotherapy: Immune Checkpoint Inhibitors, CAR T-cell Therapy, Cancer Vaccines, Cytokines, Oncolytic Virus Therapy, Other Immunotherapies
4) By Radiotherapy: External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (Brachytherapy), Systemic Radiation Therapy, Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT)
5) By Other Therapy Types: Hormone Therapy, Stem Cell Transplant, Photodynamic Therapy, Cryoablation, Hyperthermia Therapy
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., Aptadel Therapeutics S.L.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Cancer Therapy Market Characteristics

3. Cancer Therapy Market Trends And Strategies

4. Cancer Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cancer Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Cancer Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cancer Therapy Market Growth Rate Analysis

5.4. Global Cancer Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cancer Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cancer Therapy Total Addressable Market (TAM)

6. Cancer Therapy Market Segmentation

6.1. Global Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chemotherapy

Target Therapy

Immunotherapy

Radiotherapy

Other Therapy Types

6.2. Global Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Blood Cancer

Breast Cancer

Prostate Cancer

Gastrointestinal Cancer

Gynaecologic Cancer

Respiratory Or Lung Cancer

Other Cancer Types

6.3. Global Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Cancer And Radiation Therapy Centers

6.4. Global Cancer Therapy Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Alkylating Agents

Antimetabolites

Anti-Tumor Antibiotics

Topoisomerase Inhibitors

Mitotic Inhibitors

Corticosteroids

Other Chemotherapy Drugs

6.5. Global Cancer Therapy Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monoclonal Antibodies

Tyrosine Kinase Inhibitors (TKIs)

mTOR Inhibitors

Proteasome Inhibitors

PARP Inhibitors

Other Targeted Agents

6.6. Global Cancer Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immune Checkpoint Inhibitors

CAR T-cell Therapy

Cancer Vaccines

Cytokines

Oncolytic Virus Therapy

Other Immunotherapies

6.7. Global Cancer Therapy Market, Sub-Segmentation Of Radiotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

External Beam Radiation Therapy (EBRT)

Internal Radiation Therapy (Brachytherapy)

Systemic Radiation Therapy

Stereotactic Radiosurgery (SRS)

Intensity-Modulated Radiation Therapy (IMRT)

Image-Guided Radiation Therapy (IGRT)

6.8. Global Cancer Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hormone Therapy

Stem Cell Transplant

Photodynamic Therapy

Cryoablation

Hyperthermia Therapy

7. Cancer Therapy Market Regional And Country Analysis

7.1. Global Cancer Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cancer Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Therapy Market

8.1. Asia-Pacific Cancer Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Therapy Market

9.1. China Cancer Therapy Market Overview

9.2. China Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Therapy Market

10.1. India Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Therapy Market

11.1. Japan Cancer Therapy Market Overview

11.2. Japan Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Therapy Market

12.1. Australia Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Therapy Market

13.1. Indonesia Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Therapy Market

14.1. South Korea Cancer Therapy Market Overview

14.2. South Korea Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Therapy Market

15.1. Western Europe Cancer Therapy Market Overview

15.2. Western Europe Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Therapy Market

16.1. UK Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Therapy Market

17.1. Germany Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Therapy Market

18.1. France Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Therapy Market

19.1. Italy Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Therapy Market

20.1. Spain Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Therapy Market

21.1. Eastern Europe Cancer Therapy Market Overview

21.2. Eastern Europe Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Therapy Market

22.1. Russia Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Therapy Market

23.1. North America Cancer Therapy Market Overview

23.2. North America Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Therapy Market

24.1. USA Cancer Therapy Market Overview

24.2. USA Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Therapy Market

25.1. Canada Cancer Therapy Market Overview

25.2. Canada Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Therapy Market

26.1. South America Cancer Therapy Market Overview

26.2. South America Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Therapy Market

27.1. Brazil Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Therapy Market

28.1. Middle East Cancer Therapy Market Overview

28.2. Middle East Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Therapy Market

29.1. Africa Cancer Therapy Market Overview

29.2. Africa Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Therapy Market Competitive Landscape And Company Profiles

30.1. Cancer Therapy Market Competitive Landscape

30.2. Cancer Therapy Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Therapy Market Other Major And Innovative Companies

31.1. Bristol-Myers Squibb Company

31.2. AstraZeneca PLC

31.3. Novartis International AG

31.4. GlaxoSmithKline PLC

31.5. Elekta AB

31.6. Exelixis Inc.

31.7. Accuray Incorporated

31.8. Akeso Inc.

31.9. Nanobiotix S.A.

31.10. SOTIO Biotech a.s.

31.11. AdvanCell Isotopes Pty Ltd

31.12. Axcynsis Therapeutics Pte Ltd

31.13. Clarity Pharmaceuticals Ltd

31.14. Affimed N.V.

31.15. Aptadel Therapeutics S.L.

32. Global Cancer Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Therapy Market

34. Recent Developments In The Cancer Therapy Market

35. Cancer Therapy Market High Potential Countries, Segments and Strategies

35.1 Cancer Therapy Market In 2029 - Countries Offering Most New Opportunities

35.2 Cancer Therapy Market In 2029 - Segments Offering Most New Opportunities

35.3 Cancer Therapy Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Cancer Therapy Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Cancer Therapy Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Cancer Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Cancer Therapy Market, Sub-Segmentation Of Radiotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Cancer Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Cancer Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Cancer Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Pfizer Inc. Financial Performance
  • Table 80: Johnson & Johnson Financial Performance
  • Table 81: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 82: Merck & Co. Inc. Financial Performance
  • Table 83: Bayer AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Cancer Therapy Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Cancer Therapy Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Cancer Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Cancer Therapy Market, Sub-Segmentation Of Radiotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Cancer Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Cancer Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Cancer Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Pfizer Inc. Financial Performance
  • Figure 80: Johnson & Johnson Financial Performance
  • Figure 81: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 82: Merck & Co. Inc. Financial Performance
  • Figure 83: Bayer AG Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Oncology Drugs Global Market Report 2022 – By Type (Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Canc...

View Report

Blood Cancer Drugs Global Market Report 2025 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotin...

View Report

Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2025 – By Drug Type (Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies And Cancer Vaccines, Other Drug Types), By Service Type (Target...

View Report

Metastatic Cancer Drugs Global Market Report 2025 – By Drug Class (HER2 Inhibitors, Immune Checkpoints Inhibitors, PARP Inhibitors, Kinase Inhibitors, Other Drug Class), By Cancer (Breast Cancer, Lung Cancer, Liver Cance...

View Report

Cancer Insurance Global Market Report 2025 – By Type (Lung Cancer, Liver Cancer), By Insurance Plan (Individual Plan, Supplement Plan, Critical Illness Plan), By Distribution Channel (Brokers, Bancassurance, Agents, Dire...

View Report

Generic Oncology Drugs Global Market Report 2025 – By Molecule Type (Large Molecule, Small Molecule), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pha...

View Report

Pet Cancer Therapeutics Global Market Report 2025 – By Cancer Type (Melanoma, Mast Cell Cancer, Lymphoma, Mammary And Squamous Cell Cancer), By Species (Dogs, Cats, Other Species), By Therapy (Chemotherapy, Radiation The...

View Report

Glioma Treatment Global Market Report 2025 – By Type (Low-Grade, High-Grade), By Disease (Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Other Diseases), By Route Of Administration (Oral, ...

View Report

Frequently Asked Questions

Cancer therapy refers to the treatment used to eliminate or control cancer cells in the body. It includes various approaches such as surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The choice of treatment depends on the type, stage, and location of the cancer, as well as the patient's overall health. For further insights on the Cancer Therapy market, request a sample here

The Cancer Therapy market major growth driver - Rising Cancer Prevalence Driving Growth Of The Market Due To Aging Population And Growing Treatment Needs. For further insights on the Cancer Therapy market, request a sample here

The Cancer Therapy market size has grown strongly in recent years. The cancer therapy market size has grown rapidly in recent years. It will grow from $190.44 billion in 2024 to $210.44 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to the increasing prevalence of cancer worldwide, the rising adoption of chemotherapy treatments, growing awareness about early cancer diagnosis, the rising availability of oncology specialists, and growing access to hospital-based treatment services. The cancer therapy market size is expected to see rapid growth in the next few years. It will grow to $310.85 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growing demand for personalized cancer therapies, increasing focus on outpatient cancer care, rising adoption of immunotherapy, expanding access to healthcare in emerging economies, and growing incidence of lifestyle-related cancers. Major trends in the forecast period include technological advancements in cancer diagnostics, innovations in targeted drug delivery, investment in research and development of biologics, development of AI-based treatment planning, and innovation in minimally invasive cancer surgeries. For further insights on the Cancer Therapy market, request a sample here

The cancer therapy market covered in this report is segmented –
1) By Therapy Type: Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types
2) By Cancer Type: Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types
3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers

Subsegment:
1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Other Chemotherapy Drugs
2) By Targeted Therapy: Monoclonal Antibodies, Tyrosine Kinase Inhibitors (TKIs), mTOR Inhibitors, Proteasome Inhibitors, PARP Inhibitors, Other Targeted Agents
3) By Immunotherapy: Immune Checkpoint Inhibitors, CAR T-cell Therapy, Cancer Vaccines, Cytokines, Oncolytic Virus Therapy, Other Immunotherapies
4) By Radiotherapy: External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (Brachytherapy), Systemic Radiation Therapy, Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT)
5) By Other Therapy Types: Hormone Therapy, Stem Cell Transplant, Photodynamic Therapy, Cryoablation, Hyperthermia Therapy For further insights on the Cancer Therapy market, request a sample here

North America was the largest region in the cancer therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Cancer Therapy market, request a sample here.

Major companies operating in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., Aptadel Therapeutics S.L. . For further insights on the Cancer Therapy market, request a sample here.

Major trends in the Cancer Therapy market include Dr. Reddy’s Launches India’s First Immuno-Oncology Drug For Nasopharyngeal Cancer. For further insights on the Cancer Therapy market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Cancer Therapy Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon